Oncolytics Biotech Inc ONCY

Phase 3

[lonc17]

Credit to Matt Coffey for keeping the promised Phase 3 Breast Cancer Trial alive.

Remember, ONC had results from a Phase 2 in Breast Cancer more than five years ago. 

For more than 5 years, Matt Coffey has been drawing a huge salary from ONC and diluting investors by promising a phase 3 trial is coming... real soon!!!

TIme to call B.S. on the phase 3 breast cancer. 

Fortunately for MC, he now has a promised phase 3 trial in Pancreatic Cancer that should keep the gravy train rolling for another five years. 

MC is not a good CEO. He and Kirk should have been fired last summer when they played their hand so poorly with Anson.

[Quentin30]

and don't forget the patents that begin expiring in 2027... whereupon uncle tom cobbly and all will be able to trial Pela themselves...  ONCY really is running out of time...

[Noteable]

Patents are good until 2034 - 12 more years ... and then there is the FDA 13 years of marketing exclusivity for a biologic beginning from the day of approval. Take your pick.

[Noteable]

ONCY has 2 phase 3 ready indications and possibly a third - all as confirmatory studies after potential Accelerated Approvals first.

[inthno]

from an earlier onc presentation ¡ More than 415 patents issued worldwide, including 61 US and 20 Canadian ¡ Reovirus issue patent claims cover: • Compositions of matter comprising reovirus • Through 2028 ONC has now changed what they say about the patents and don't tell you the expiry anymore, they just say they are extendable. they keep saying that the patents are extendable so

[Noteable]

Through to 2028 + 6 years extension = 2034 

[Noteable]

Through 2028 means past 2028.